SCHEMBL4031880

SCHEMBL4031880

O=C(c1ccc2c(ccc3occc32)c1)c1cn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cn1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTNNB1 P35222 2/20 0.34
WNT3A P56704 2/20 0.34
ENPP2 Q13822 1/20 0.33
SIRT2 Q8IXJ6 7/20 0.32
ALDH1A1 P00352 2/20 0.31
MAPT P10636 2/20 0.31
HPGD P15428 1/20 0.31
MEN1 O00255 2/20 0.30
KMT2A Q03164 2/20 0.30
KDM4E B2RXH2 1/20 0.30
USP2 O75604 1/20 0.30
LMNA P02545 1/20 0.30
POLB P06746 1/20 0.30
RECQL P46063 1/20 0.30
RAB9A P51151 1/20 0.30
BLM P54132 1/20 0.30
MCL1 Q07820 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
CNR2 P34972 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1414929 0.80 SIRT2 (0.36) SIRT2ALDH1A1MAPTHPGDMEN1
SCHEMBL4030987 0.79 MEN1 (0.51) ENPP2SIRT2MAPTMEN1KMT2A
SCHEMBL4023986 0.78 VNN1 (0.36) CTNNB1WNT3AENPP2SIRT2ALDH1A1
SCHEMBL4027506 0.77 ENPP2 (0.31) ENPP2SIRT2
SCHEMBL4029004 0.76 NPC1 (0.37) CTNNB1WNT3AENPP2ALDH1A1MAPT
SCHEMBL4024355 0.76 SIRT2 (0.41) SIRT2MAPTRAB9A
SCHEMBL313125 0.76 ACSS2 (0.43) SIRT2
SCHEMBL5678341 0.76 KDM4E (0.46) SIRT2ALDH1A1HPGDMEN1KMT2A
SCHEMBL1414832 0.76 SIRT2 (0.37) SIRT2ALDH1A1MAPTKDM4ERAB9A
SCHEMBL1414925 0.76 SIRT2 (0.34) SIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1222174-B1 IMIDAZOL-4-YLMETHANOLS USED AS INHIBITORS OF STEROID C17-20 LYASE TAKEDA PHARMACEUTICAL (JP) 2009-05-27 EP disclosed
US-6649643-B1 Antitumor, anticarcinogenic, and antimetastasis agents; benign prostatic hyperplasia, alopecia, endometriosis, uterine myoma, hirsutism, virilism, precocious puberty, mastopathy, and polycystic overay syndrome treatment TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-11-18 US disclosed